The principal glucocorticoid secreted by the human adrenal cortex is cortisol, at a rate of about 60 !Lmol/ day ( Fig. 1 ). Less than 1 % of the secreted cortisol is excreted unchanged in the urine. Cortisol is metabolised in the liver, and the metabolites are excreted as water-soluble glucuronides (Fig. 2) . Approximately 80 % of cortisol is excreted as 17-hydroxy-corticosteroids, and between 5 %and 10 %undergoes further
catabolism and is excreted as ll-oxygenated 17oxosteroids. In normal subjects, a small amount of the precursors of cortisol is secreted. 17ot-Hydroxyprogesterone is metabolised mainly to pregnanetriol and to 17ot-hydroxypregnanolone, while l l-deoxycortisol is metabolised mainly to tetrahydro ll-deoxycortisol and to pregnanetetrol. In pathological conditions where there is a deficiency of21-or l l-hydroxylase, the metabolites of 17ot-hydroxyprogesterone and l I-deoxycortisol form the major component of the 17-hydroxycorticosteroid metabolites excreted. As with cortisol metabolism there is some further catabolism of these steroids to give ll-deoxy 17-oxosteroids.
17-0xosteroids arise not only from the metabolism of adrenal steroids and from adrenal secretion but also from the ovary and testis. 17-0xosteroids in urine therefore comprise a mixture of ll-oxy and ll-deoxy 17-oxosteroids of adrenal origin as well as l l-deoxy 17-oxosteroids of gonadal origin. The gonadal contribution to this pool of 11deoxy 17-oxosteroids is primarily from the metabolism of tJ. 4-androstenedione ( Fig. 3 ). tJ. 4. Androstenedione is one of the important androgens secreted by the gonads of both males and females, approximately 40% arising from this source. In males, conversion of tJ.-androstenedione into testosterone dominates (testicular production of testosterone is approximately 24 umol/day), whereas in females, oestrogen synthesis within the ovary is the normal biosynthetic pathway for tJ. 4-androstenedione.
More comprehensive details of adrenal and gonadal steroid metabolism are to be found in several revlews.v"
Methodology
Tn 1936, Zimmermann-first introduced his method for the measurement of urinary 17-oxosteroids based 17 . r"'~Y""."-" Sometimes it is easy to delete old assays from the clinical chemistry repertoire just because they are based on out-dated methods. For methods to demonstrate 'staying power', they must fulfil a clinical need as well as have some worthwhile attributes such as simplicity and low cost. In the case of 17-oxogenic and 17-oxosteroids, in spite of their historical value in the investigation of steroid metabolism, there are several objections to these assays being retained.
The residue is then treated with a modified Zimmermann reagent (m-dinitrobenzone and aqueous benzyl trimethyl ammonium hydroxide) to give a violet complex, the absorbance of which at 520 nm is directly proportional to the 17-oxosteroids present, and a reflection of androgen production from adrenal and gonadal sources.
The case for deleting the assay of 17-oxogenic and 17-oxosteroids from the clinical chemistry repertoire ANALYTICAL PROBLEMS (l) There is a marked difference between the effective molar absorbance coefficients of the products formed by the Zimmermann reagents from the different 17oxosteroids excreted or formed by oxidation. The values obtained by Sobel et a/. 10 are shown in Table I . Therefore, variations in the relative proportions of the urinary steroids may cause considerable differences in the apparent molar concentration, and, conversely, major changes in molar concentration may be masked by a change in the pattern of steroid excretion. Besides the problem of differences in effective molar absorbance coefficients, the Zimmermann chromogens are light-sensitive and unstable. 11 (2) Some of the solvents and reagents used are unpleasant or potentially hazardous. Ether presents a fire risk, and m-dinitrobenzene and ethylene chloride are toxic. Against these hazards should be weighed the low risks of using radioactive tracers used in radioimmunoassay techniques for steroid determinations.
(3) The precision is poor. Table 2 lists the coefficients of variation for the group mean on four different occasions for 38 laboratories (17-oxosteroids) and 32
upon the purple colour that develops when a steroid with a C-17 oxo group is treated with m-dinitrobenzene in the presence of alkali. In 1952, Norymberski" modified the method to include the estimation of 17-oxogenic steroids, which, as their name implies, are 17-hydroxysteroids that can be oxidised to 17oxosteroids, Treatment of the urine sample with sodium bismuthate splits off the side chain in the C-17 position and oxidises the C-17 hydroxyl group (Fig. 4) . The difference between the estimated amount of 17-oxosteroids before and after treatment with sodium bismuthate is a measure of the 17-oxogenic steroids. The main disadvantage of the technique is the need for two separate measurements. Moreover, in certain pathological conditions, in particular congenital adrenal hyperplasia," some of the 20:21 deoxysteroid metabolites (eg, 17a.-hydroxypregnanolone) are not measured. To overcome these problems Appleby et a/. 7 pretreated urinary extracts with potassium borohydride. This reduces preformed neutral 17-oxosteroids to secondary alcohols that do not react with the Zimmermann reagent, and reduces steroids with an oxo group at the C 20 position to corresponding hydroxy derivatives which may then be oxidised by sodium bismuthate and subsequently assayed as 17-oxosteroids. Most British laboratories have adopted this approach with some modifications, the most important of which is substitution of sodium metaperiodate for sodium bismuthate as oxidant, as described by Few" and recommended by a Working Party of the Medical Research Council in 1969. 9 The Working Party also provided guidelines for the measurement of 17oxosteroids in urine, for which the procedure is even simpler than that for 17-oxogenic steroids. Briefly, an acid hydrolysate of urine is extracted with ethylene chloride, which is washed and evaporated. 17-0xogenic steroid excretion has been used to monitor adrenal glucocorticoid secretion and to detect excessive production of 21-deoxysteroids in patients with congenital adrenal hyperplasia. Measurements of these biologically inactive products were of limited use before more specific assays became available. In severe Cushing's syndrome, the concentrations may be high but the measurement of serum cortisol or urinary free cortisol is more specific and sensitive. Faster and more precise methods are now available for these assa.ys.1618
In those cases in which 17-oxogenic steroids may be used to confirm a diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, measurement of the specific urinary metabolite (pregnanetriol) or serum 17-hydroxyprogesterone is more helpful and reliable.!" CLINICAL SIGNIFICANCE OF URINARY 17-oXOSTEROID EXCRETION In the female, androgens are almost entirely of adrenal origin, and in the male 70% is from this source. Testosterone, the principal androgen produced in the male, is not itself a 17-oxosteroid but has a hydroxyl group at the C-17 position, and only about 25 % is converted into 17-oxosteroids. The assay of 17-oxosteroids can give only a rough guide as to the secretion rate of androgens from the adrenal cortex and is a poor reflection of testicular function.
In the polycystic ovary syndrome, the 17-oxosteroid excretion may be normal when the serum testosterone is substantially increased.P The 17oxosteroids also include many different androgens and their metabolites, many of which are biologically inactive. Because of the difficulty in measuring low levels of 17-oxosteroids, the estimation is of little use in discriminating between normal and low excretion rates.
Since the estimation of serum concentrations of the relevant'androgens can now be measured simply and precisely, they should replace the measurement of urinary 17-oxosteroids. low concentrations of 17-oxogenic and 17-oxosteroids in neonatal urine cannot be measured reliably. (6) Cost should have little influence in the choice of a method if the measurement is of great clinical value and has good analytical precision. However, the 17oxogenic and 17-oxosteroid assays are labourintensive, and because of this the total costs are high. This remains true even when automation of the colorimetric measurement-s is utilised in these assays.
17.oxogenlc steroids
RIAll.) 6·0 17·0 § GLC/RIA (10)11·3--12·9 ID RIA (17) 7·5-11·9 ID RIA (27) 7·2-15·5 15·111 RIA (28) 5·1-12·3 with the better precision of radioimmunoassays for individual steroid hormones, which are also given in Table 2 . Part of the poor performance for urinary 17-oxogenic and 17-oxosteroids may be due to the infrequency with which some laboratories perform these assays. Inaccuracy of 24-hour urine collections is also another potential source of serious error, although this will of course affect all estimations of urine metabolites.
(4) Specificity is often lacking, especially if other chromogens are present, as is the case with concentrated urine specimens from infants. Compensation for these errors by solvent partition techniques-" or by taking readings at three different wavelengths is feasible but complicates the method and is not always reliable. The presence of large quantities of glucose in the urine may give low results as it competes with the steroids for the oxidising agent. Enzymatic or selective chemical oxidation of the glucose has been advocated, but these steps add to the complexity of the assay, and not all laboratories test routinely for glucose. (5) Due to the poor sensitivity of the methods, the
Urinary 17-oxogenic and 17 oxosteroids
As with 17-oxosteroids, measurement of the basal excretion of 17-oxogenic steroids is a very poor indicator when assessing adrenal hypofunction. Stimulation tests using ACTH or Synacthen have to be much more prolonged when urinary steroids are measured. When plasma steroids are measured, smaller doses of ACTH can be used and the test can be completed in hours rather than days.
Thus there is no clinical indication for the retention of 17-oxogenic steroids.
What are the alternatives?
The choice of appropriate steroids to measure in blood or urine should be determined by clinical assessment of the patient's symptoms and related to the results of other investigations. This is illustrated in the following examples.
SUSPECTED CUSHING'S SYNDROME
Adrenocortical function is best assessed by measuring urinary free cortisol excretion, if renal function is normal, and the circadian rhythm of serum cortisol (at 0800 hand 2400 h), although some obese, stressed, and hospitalised patients may lose this rhythm without evidence of Cushing's syndrome. The short, and occasionally the long, dexamethazone suppression tests provide additional diagnostic information. When adrenocortical hyperfunction has been confirmed, plasma ACTH should also be measured to help distinguish primary pituitary, ectopic, and adrenal causes.
ADRENAL INSUFFICIENCY SYNDROMES
Adrenal insufficiency can occur in association with other endocrine diseases and may be due to destruction of the adrenal cortex (Addison's disease) or consequent upon impaired secretion of ACTH. In either case, inappropriately low or undetectable concentrations of serum cortisol are commonly observed. In addition, a poor or absent cortisol response to a Synacthen test should be used to confirm the diagnosis. CONGENITAL ADRENAL HYPERPLASIA This is a relatively rare disease of infancy with an incidence of 1 in 5()()()....6()()() live births in Britain, of which one-third present with salt loss. A variant of the disease can also present after puberty. Early diagnosis and treatment is essential since the disease is life-threatening in its salt-losing form. A correct diagnosis is most easily made by the measurement of serum 17ot-hydroxyprogesterone. The assay of serum testosterone can support the diagnosis, especially if masculinisation of female genitalia is a 69 presenting feature. Less diagnostic value can be placed on the measurement of serum dehydroepiandrosterone sulphate (DHAS), especially in infants, because the secretion rate of this steroid from the normal fetal adrenal gland is high. In the absence of facilities for measuring serum 17ot-hydroxyprogesterone, urinary pregnanetriol provides a useful diagnostic aid. This is especially true if a gas chromatographic technique is available for the identification of specific urinary metabolites, which may, in addition, indicate the presence of other adrenocortical enzyme deficiencies.
The best choice of a steroid assay as a monitor of the adequacy of steroid replacement therapy in patients with 21-hydroxylase deficiency is not entirely settled.
The frequent measurement of 17ot-hydroxyprogesterone in serum.'" or possibly saliva;" has been advocated. However, f:::, 4-androstenedione may be a better indicator of adequate control.P' ADRENAL ADENOMA (ANDROGEN SECRETING)
The only presenting symptom may be excessive hirsutism or, in the case of children, accelerated growth and advanced bone age. Dehydroepiandrosterone sulphate (DHAS) is the hormone assay of choice, supplemented by serum testosterone measurements in a female patient. In the adult male patient, testosterone measurements are of less value because of the testicular contribution.
Precocious sexual development in prepubertal boys can arise from diseases other than adrenal adenomas or congenital adrenal hyperplasia. It is rare, but well documented." that bilateral enlargement of the testes is associated with precocious sexual development and increased testosterone production for age. A raised concentration of serum testosterone coincidental with a raised luteinising hormone (LH) suggests true isosexual precocity. Normal or slightly raised LH and testosterone concentrations may indicate a more sinister cause for the precocity. In this circumstance, measurements of f:::, 4-androstenedione and 17ot-hydroxyprogesterone are warranted, because serum concentrations of these steroids are raised in the presence of a Leydig cell tumour.22
POLYCYSTIC OVARY DISEASE
One of the causes of anovulatory problems and hirsutism in the female is polycystic disease of the ovary. Useful assays are DHAS, f:::, 4-androstenedione (since approximately 50 % of patients have elevated concentrations of this steroid), and testosterone, which is commonly present in high ccncentration.P LH is also commonly elevated in this condition. However, a differential diagnosis from other causes of female hirsutism cannot be made by steroid hormone measurements alone. Several publications describe some of the clinical problems and additional hormone assays required for a firm diagnosis.P 24
MALE HYPOGONADISM
The causes of this condition are legion although it is rare. The measurement of choice is serum testosterone, the concentration of which may be low if gonadotrophin synthesis is impaired or if a testicular enzyme deficiency is present. If a 5oc.-reductase deficiency is suspected.v the measurement of serum dihydrotestosterone is recommended.
In testicular feminising syndrome (male pseudohermaphroditism), the serum testosterone is raised. For detailed discussions of these and other rare diseases of testicular malfunction the review by London is recommended.26 Table 3 lists suitable steroids to measure in the clinical conditions outlined above.
It is frequently argued that the measurement of steroids in blood is not a true reflection of secretion, because specimens are normally taken at a single point in time. This criticism can be largely offset by frequent sampling and pulsatile studies. There is also now the special opportunity to sample at very frequent intervals those steroids present in saliva, with minimum discomfort and inconvenience to the patient.
Well-defined reference ranges for sex and age for some of the steroids in blood also contribute significantly to a correct and reliable diagnosis.
It is recommended that efforts should continue towards developing clinically useful steroid assays of appropriate cost, speed, precision, and, particularly, specificity. 17-0xogenic steroid assays should 
